Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 10,160 | 15,663 | 17,571 | 26,251 | 39,252 |
| Operating Income | -10,160 | -15,663 | -17,571 | -26,251 | -39,252 |
| Other Income | 44 | 283 | 4,150 | 10,759 | 11,449 |
| Pre-tax Income | -10,116 | -15,380 | -13,421 | -15,492 | -27,803 |
| Net Income Continuous | -10,116 | -15,380 | -13,421 | -15,492 | -27,803 |
| Minority Interests | -73 | -77 | -54 | -318 | -548 |
| Net Income | $-10,043 | $-15,303 | $-13,367 | $-15,174 | $-27,255 |
| EPS Basic Total Ops | -165.00 | -245.00 | -1,015.00 | -1,557.50 | -2,534.97 |
| EPS Basic Continuous Ops | -133.03 | -233.91 | -538.39 | -1,090.07 | -2,577.51 |
| EPS Diluted Total Ops | -165.00 | -245.00 | -1,015.00 | -1,557.50 | -2,534.97 |
| EPS Diluted Continuous Ops | -133.03 | -233.91 | -538.39 | -1,090.07 | -2,577.51 |
| EPS Diluted Before Non-Recurring Items | -165.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,959 | $-15,423 | $-17,299 | $-26,006 | $-39,095 |